It has been shown that METTL14 acts as a tumor suppressor in colorectal cancer (CRC) [6, 7], bladder cancer [8] and breast cancer [9], but represents an oncogenic factor in thyroid cancer [10], pancreatic cancer [11] and leukemogenesis [12]. This evidence concerns the gene METTL14 and breast cancer.